Methods and compositions for applying moxifloxacin to the ear

Details for Australian Patent Application No. 2011204275 (hide)

Owner Regents of the University of Minnesota Novartis AG

Inventors Sawchuk, Ronald J.; Cheung, Belinda W.Y.; Wall, G. Michael

Agent Pizzeys

Pub. Number AU-A-2011204275

PCT Pub. Number WO2011/085209

Priority 61/293,019 07.01.10 US

Filing date 7 January 2011

Wipo publication date 14 July 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/437

A61K 47/30 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/36 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 27/16 Drugs for disorders of the senses

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/085209 Priority application(s): WO2011/085209

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204277-Fatty Acid Fumarate Derivatives and their uses

2011204270-Evaluating and reporting measurments for H(e) NB outbound mobility and interH(e)NB mobility in connected mode